Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raphael Schiffmann

Showing results (21-30 of 225) with videos related to

Pageof 23
Sort By:
The New England Journal of Medicine|November 25, 2003
Images in clinical medicine. Fabry's diseaseJeffrey B Kopp, Raphael Schiffmann
Neurology|April 21, 2012
Decision support for diagnosis: co-evolution of tools and resourcesMichael M Segal, Raphael Schiffmann
Neurology|December 12, 2018
Cerebrotendinous xanthomatosis: The rare "treatable" disease you never considerGerald V Raymond, Raphael Schiffmann
Neurology. Genetics|April 29, 2016
Long-term follow-up and sudden unexpected death in Gaucher disease type 3 in EgyptMagy Abdelwahab, Derek Blankenship, Raphael Schiffmann
Journal of the American Society of Nephrology : JASN|June 18, 2002
Natural history and treatment of renal involvement in Fabry diseaseMary Branton, Raphael Schiffmann, Jeffrey B Kopp
Neurology|June 30, 2005
Effect of genetic modifiers on cerebral lesions in Fabry diseaseGheona Altarescu, David F Moore, Raphael Schiffmann
Neurology|February 25, 2009
Invited article: an MRI-based approach to the diagnosis of white matter disordersRaphael Schiffmann, Marjo S van der Knaap
Current Opinion in Neurology|March 17, 2004
The latest on leukodystrophiesRaphael Schiffmann, Marjo S van der Knaap
Arteriosclerosis, Thrombosis, and Vascular Biology|June 22, 2007
Elevated endothelial microparticles in Fabry children decreased after enzyme replacement therapyMonique P Gelderman, Raphael Schiffmann, Jan Simak
Molecular Genetics and Metabolism|February 27, 2009
Falsely elevated urinary Gb3 (globotriaosylceramide, CTH, GL3)Sabrina Forni, Xiaowei Fu, Raphael Schiffmann, et al.
Pageof 23

Showing results (21-30 of 225) with videos related to

Sort By:
Pageof 23
The New England Journal of Medicine|November 25, 2003
Images in clinical medicine. Fabry's diseaseJeffrey B Kopp, Raphael Schiffmann
Neurology|April 21, 2012
Decision support for diagnosis: co-evolution of tools and resourcesMichael M Segal, Raphael Schiffmann
Neurology|December 12, 2018
Cerebrotendinous xanthomatosis: The rare "treatable" disease you never considerGerald V Raymond, Raphael Schiffmann
Neurology. Genetics|April 29, 2016
Long-term follow-up and sudden unexpected death in Gaucher disease type 3 in EgyptMagy Abdelwahab, Derek Blankenship, Raphael Schiffmann
Journal of the American Society of Nephrology : JASN|June 18, 2002
Natural history and treatment of renal involvement in Fabry diseaseMary Branton, Raphael Schiffmann, Jeffrey B Kopp
Neurology|June 30, 2005
Effect of genetic modifiers on cerebral lesions in Fabry diseaseGheona Altarescu, David F Moore, Raphael Schiffmann
Neurology|February 25, 2009
Invited article: an MRI-based approach to the diagnosis of white matter disordersRaphael Schiffmann, Marjo S van der Knaap
Current Opinion in Neurology|March 17, 2004
The latest on leukodystrophiesRaphael Schiffmann, Marjo S van der Knaap
Arteriosclerosis, Thrombosis, and Vascular Biology|June 22, 2007
Elevated endothelial microparticles in Fabry children decreased after enzyme replacement therapyMonique P Gelderman, Raphael Schiffmann, Jan Simak
Molecular Genetics and Metabolism|February 27, 2009
Falsely elevated urinary Gb3 (globotriaosylceramide, CTH, GL3)Sabrina Forni, Xiaowei Fu, Raphael Schiffmann, et al.
Pageof 23